Roundup Settlement Deadline Approaches: What Pennsylvania Cancer Victims Need to Know Before June 4
Lancaster, United States – May 13, 2026 / Rankin & Gregory, LLC (RG Injury Law) /
LANCASTER, PA – May 12, 2026 – With a court-imposed opt-out deadline of June 4, 2026 approaching fast, Lancaster-based RG Injury Law is alerting Pennsylvania residents diagnosed with non-Hodgkin lymphoma after Roundup exposure that the window to make an irreversible legal decision is closing. Bayer’s proposed $7.25 billion class settlement received preliminary approval in March 2026, but accepting it permanently waives a claimant’s right to pursue an independent lawsuit.

$7.25 Billion Settlement Leaves Key Questions Unanswered
Bayer structured the deal to resolve both current and future non-Hodgkin lymphoma claims over a 21-year payment window. The company retains the right to walk away if participation falls short of near-universal buy-in. For claimants evaluating the offer, the terms carry real consequences:
-
Roughly 61,000 to 65,000 active Roundup claims remain nationwide
-
Opting out requires satisfying 11 separate procedural requirements
-
Missing a single requirement could invalidate the opt-out entirely
-
The settlement compensation follows a point-based tier system tied to diagnosis severity, exposure duration, age, and treatment intensity
In the first settlement wave, payouts ranged from $100,000 to $160,000. Phase 2 numbers are unlikely to trend higher given Bayer’s sharply reduced financial position since acquiring Monsanto.

Supreme Court Ruling Could Reshape the Entire Litigation
Every claimant deciding whether to opt out is also betting on a Supreme Court outcome. In April 2026, the Court heard arguments in Monsanto v. Durnell, a case centered on whether federal pesticide labeling law blocks state failure-to-warn claims entirely. A ruling in Bayer’s favor would gut the legal foundation for thousands of independent lawsuits. A decision is expected later this year.
“Pennsylvania residents who used Roundup and later developed non-Hodgkin lymphoma deserve to understand exactly what they are agreeing to before June 4,” said Chad Rankin, Personal Injury Attorney at RG Injury Law. “Accepting this settlement is a permanent decision, and the procedural requirements for opting out are not forgiving. Getting informed legal counsel now is the most important step a claimant can take.”
The Pennsylvania Superior Court upheld a $175 million Roundup verdict in May 2025, affirming that state-level claims carry real weight. The Third Circuit’s 2024 preemption ruling, however, created competing legal pressure that now sits before the Supreme Court.
Claimants with a recent NHL diagnosis, a pending claim, or an unclear statute of limitations timeline should contact a personal injury attorney before the deadline.
Every week of delay shrinks the options available.
About RG Injury Law
Rankin & Gregory, LLC serves Lancaster County and surrounding Pennsylvania communities as RG Injury Law, operating four offices across Lancaster, Leola, Columbia, and Lancaster County. The firm handles personal injury, auto accident, and workers’ compensation cases with direct, community-focused representation for south-central Pennsylvania residents.
Media Contact:
RG Injury Law Chad Rankin,
Personal Injury Attorney
1476 Lititz Pike, Lancaster, PA 17601
(717) 656-5000
help@rginjurylaw.com
Contact Information:
Rankin & Gregory, LLC (RG Injury Law)
1476 Lititz Pike
Lancaster, PA 17601
United States
Public Relations
(717) 656-5000
https://www.rginjurylaw.com/
Original Source: https://www.rginjurylaw.com/media-room/
